ACHV - Achieve Life Sciences GAAP EPS of -$0.83 beats by $0.06
2023-03-16 16:18:35 ET
- Achieve Life Sciences press release ( NASDAQ: ACHV ): Q4 GAAP EPS of -$0.83 beats by $0.06 .
-
As of December 31, 2022, the company’s cash, cash equivalents, and restricted cash was $24.8 million.
-
Total operating expenses for the fourth quarter and year ended December 31, 2022 were $10.9 million and $40.8 million, respectively.
-
Total net loss for the fourth quarter and year ended December 31, 2022 was $11.2 million and $42.4 million, respectively.
-
As of March 16, 2023 Achieve had 17,930,362 shares outstanding.
For further details see:
Achieve Life Sciences GAAP EPS of -$0.83 beats by $0.06